Showing results (121-130 of 127) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 127 results.
Journal of Medicinal Chemistry|November 2, 2019
Drug Design Targeting T-Cell Factor-Driven Epithelial-Mesenchymal Transition as a Therapeutic Strategy for Colorectal CancerAdedoyin D Abraham, Hector Esquer, Qiong Zhou, et al.
Cancer Research|July 26, 2018
Phase Ib Results of the Rational Combination of Selumetinib and Cyclosporin A in Advanced Solid Tumors with an Expansion Cohort in Metastatic Colorectal CancerAnuradha Krishnamurthy, Arvind Dasari, Anne M Noonan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 13, 2013
Rational combination of a MEK inhibitor, selumetinib, and the Wnt/calcium pathway modulator, cyclosporin A, in preclinical models of colorectal cancerAnna Spreafico, John J Tentler, Todd M Pitts, et al.
Neuro-Oncology|July 24, 2023
EYA2 tyrosine phosphatase inhibition reduces MYC and prevents medulloblastoma progressionArthur R Wolin, Melanie Y Vincent, Taylor Hotz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 17, 2020
Preclinical and Dose-Finding Phase I Trial Results of Combined Treatment with a TORC1/2 Inhibitor (TAK-228) and Aurora A Kinase Inhibitor (Alisertib) in Solid TumorsS Lindsey Davis, Anastasia A Ionkina, Stacey M Bagby, et al.
Cancer Research|April 29, 2020
Identification of a Small-Molecule Inhibitor That Disrupts the SIX1/EYA2 Complex, EMT, and MetastasisHengbo Zhou, Melanie A Blevins, Jessica Y Hsu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 23, 2021
Adjuvant Sirolimus Does Not Improve Outcome in Pet Dogs Receiving Standard-of-Care Therapy for Appendicular Osteosarcoma: A Prospective, Randomized Trial of 324 DogsAmy K LeBlanc, Christina N Mazcko, Aswini Cherukuri, et al.
Pageof 13